Veru Inc. (VERU) Social Stream

Veru Inc. (VERU): $7.56

0.31 (+4.28%)

POWR Rating

Component Grades













Featured Post From StockTwits About VERU

$VERU earning coming up on the 12 look at the massive runs in the past leading up to earning I think this is gonna be a blow out of the park for a lot of investors who don’t get in on this. Can’t wait for everyone to profit from this ultimate setup. Prediction: run starts Wednesday and leads up all the way into earnings and a massive run the day after from an after hours run! Good luck to all!
bigbagben, published April 30, 2021

What Else are VERU Traders Talking About?

Other tickers frequently mentioned alongside VERU are MMEDF, SPWR, BOXL and WKHS.

Other Notable StockTweets About VERU

$VERU Next take-off: May 5-8 :)
MIAMI, April 21, 2021 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer, today announced that clinical results from the Phase 2 clinical study of enobosarm, a selective androgen receptor targeting agonist, in heavily pretreated women with AR+ER+HER2- advanced breast cancer including further efficacy data and an analysis of patients who have failed both estrogen blocking agents and CDK 4/6 inhibitors, has been accepted for a poster presentation at the European Society for Medical Oncology (ESMO) Breast Cancer Virtual Congress 2021 to be held May 05-08, 2021.
Abstract Title: Efficacy of enobosarm, a selective androgen receptor (AR) targeting agent, in patients with metastatic AR+ER+ breast cancer resistant to estrogen receptor targeted agents and CDK 4/6 inhibitor in a Phase 2 clinical study

Bud___Fox, published April 24, 2021

Listening to Warren Buffett use humor to poke fun at us impatient investors is always funny but (as usual) brilliantly said. Thinking long term is the smartest, safest & most financially rewarding strategy anyone could have, so, unless you’re shorting or day trading, there’s nothing to minute panic about.
We know these sectors are oversold & will eventually recover, even if this long market volatility makes it seem otherwise. Watching the day to day will also tempt many to sell at a loss, even though these are actually the best times to buy. But, if that’s not possible, remember, holding strong is free and just as profitable for those that wait it out. If you’re leveraged, keep working and pay it off but whatever you do, don’t give back your valuable holdings ((with interest)) and miss out later when the market soars like it always does..

AlwaysFaithful2020, published April 20, 2021

$VERU serious question..... how do you even invest in companies anymore? You used to be able to listen to CC’s and get the earnings reports and try to build a case to invest in the company. Now you do that and CEO’s tell you what you want to hear and do the opposite or fluff the earnings or fluff the trials it’s just so much harder at least it seems anyways.

Tbabs, published April 16, 2021

$VERU VERU seems to like Morgan Stanley (and vice versa)

Morgan Stanley reports 872.90% increase in ownership of VERU / Veru Inc
2021-02-16 - Morgan Stanley has filed a 13F-HR form disclosing ownership of 235,773 shares of Veru Inc (US:VERU) with total holdings valued at $2,040,000 USD as of 2020-12-31. Morgan Stanley had filed a previous 13F-HR on 2020-11-13 disclosing 24,234 shares of Veru Inc at a value of $63,000 USD. This represents a change in shares of 872.90 percent and a change in value of 3,138.10 percent during the quarter.

MIAMI, March 08, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate cancer and breast cancer, today announced that it has engaged Morgan Stanley & Co. LLC as a financial advisor to assist the Company and its management in pursuing strategic alternatives regarding its legacy FC2 Female Condom(R) / FC2 Internal Condom business (FHC Business).

RiverBottomBluze, published April 10, 2021

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5507 seconds.